A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight

StatusUnknown
PhasePhase 2
Started

Record status This record was last updated September 24, 2024 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Eligibility criteria expanded, about 17 wordsv2
  3. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
MindRank AI Ltd
6 trials monitored
See all monitored trials
Obesity
3,888 trials monitored
See 157 trials at risk
This is a 24 weeks, multicenter, randomized, double-blind, placebo, parallel-controlled Phase IIb trail comparing the efficacy and safety of MDR-001 tablet versus placebo as an adjunct to a reduced calorie diet and increased physical activity in subjects with overweight or obesity, and to explore the optimal dose selection to support the subsequent Pivotal trial.
Trial Details
NCT Number NCT06606483
Lead Sponsor MindRank AI Ltd
Conditions
(from sponsor)		 Obesity, Overweight and Obesity
Related terms Obesity, Overweight
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov